Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Armata Pharmaceuticals Inc (ARMP)

44 + Investors. Track Smart Money conviction in ARMP. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +8
Streak
2Q ▲
Buyers last Q
75%

Smart Money Signals — ARMP

Based on 44 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added ARMP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
44 hedge funds hold ARMP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +76% more funds vs a year ago

fund count last 6Q
+19 new funds entered over the past year (+76% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 75% buying

24 buying8 selling
Last quarter: 24 funds were net buyers (12 opened a brand new position + 12 added to an existing one). Only 8 were sellers (4 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~12 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 5 → 2 → 13 → 12. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

41% of holders stayed for 2+ years

41% conviction (2yr+) 18% medium 41% new
18 out of 44 hedge funds have held ARMP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +409% but shares only +215% — price-driven

Value
+409%
Shares
+214%
Last quarter: the total dollar value of institutional holdings rose +409%, but actual share count only changed +215%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

2 → 5 → 2 → 13 → 12 new funds/Q
New funds entering each quarter: 5 → 2 → 13 → 12. A growing number of institutions are discovering ARMP each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 57% veterans vs 36% newcomers

57% veterans 7% 1-2yr 36% new
Entry-cohort mix of 44 holders: 25 (57%) are 2+ year veterans, 3 entered 1–2 years ago, and 16 (36%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 16% AUM from top-100

16% from top-100 AUM funds
15 of 44 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.0
out of 10
Moderate Exit Risk
Exit risk score 5.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ARMP

In 2026 Q1, 24 hedge funds were net buyers of ARMP (12 opened a new position, 12 added to an existing one), while 8 reduced or exited (4 trimmed, 4 sold completely) — a 75% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +8 funds (more new holders than closures). Total institutional holders: 44.

Hedge Fund Ownership: ARMP

How many hedge funds hold ARMP — quarterly history vs. share price
Quarterly hedge fund ownership of ARMP vs. share price

Market Analysis: ARMP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ARMP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Armata Pharmaceuticals Inc (ARMP) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ARMP has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 85d ago
ARMP
-31.5%
XLV
+2.8%

ARMP outperformed XLV by -34.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 40d ago
ARMP
-12.9%
XLV
+3.9%

Since the filing became public, ARMP outperformed XLV by -16.8% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 0 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
0.2
/ 10
conviction
Hedge Fund Positioning: ARMP
44 + Investors

Track Smart Money conviction in ARMP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 44 36 22.22%
13F Shares 4M 1M 214.59%
Total Value $40M $8M 409.03%
New Positions 12 13 -1
Increased Positions 12 11 +1
Closed Positions 4 4 -
Reduced Positions 4 2 +2
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ARMP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

44 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ARMP. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ARMP holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Dauntless Investment Group, LLC 0.61% 90,580 $928K
2 Madison Asset Management, LLC 0.27% 2,107,675 $21.6M
3 683 Capital Management, LLC 0.07% 137,000 $1.4M
4 Informed Momentum Co LLC 0.07% 60,955 $624K
5 Grey Ledge Advisors, LLC 0.07% 30,000 $307K
6 SeaCrest Wealth Management, LLC 0.05% 41,524 $425K
7 Bridgeway Capital Management, LLC 0.01% 44,682 $458K
8 Edgewood Management LLC 0.01% 100,000 $1.0M
9 Cornerstone National Bank & Trust Co 0.01% 1,428 $15K
10 Measured Wealth Private Client Group, LLC 0.00% 1,000 $10K
11 Silver Grove Financial Group, Inc. 0.00% 200 $2K
12 Trifecta Capital Advisors, LLC 0.00% 714 $7K
13 Millennium Management LLC 0.00% 257,992 $2.6M
14 Sei Investments Co 0.00% 74,192 $760K
15 Hudson Bay Capital Management LP 0.00% 17,584 $180K
16 Renaissance Technologies LLC 0.00% 38,496 $394K
17 Team Financial Group, LLC 0.00% 71
18 Qube Research & Technologies Ltd 0.00% 26,628 $273K
19 Hrt Financial LP 0.00% 10,595 $108K
20 Captrust Financial Advisors 0.00% 13,140 $135K
21 Vanguard Fiduciary Trust Co 0.00% 67,864 $695K
22 Vanguard Capital Management LLC 0.00% 366,028 $3.7M
23 Susquehanna International Group, LLP 0.00% 64,759 $663K
24 Tower Research Capital LLC (TRC) 0.00% 277 $3K
25 Goldman Sachs Group Inc 0.00% 60,953 $624K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Armata Pharmaceuticals Inc (ARMP)

What does the Smart Money Trend signal show for ARMP?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added ARMP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ARMP?

More buyers than sellers — 75% buying: Last quarter: 24 funds were net buyers (12 opened a brand new position + 12 added to an existing one). Only 8 were sellers (4 trimmed + 4 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ARMP holders?

Smaller funds dominant — 16% AUM from top-100: 15 of 44 holders rank in the top 100 by AUM, but together hold only 16% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ARMP?

41% of holders stayed for 2+ years: 18 out of 44 hedge funds have held ARMP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Armata Pharmaceuticals Inc (ARMP) following the 2026 Q1 hedge fund 13F filings?

As of today, ARMP has moved -12.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of -16.8%. Since the quarter end (March 31, 2026), ARMP has gained -31.5% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →